People who have severe toothache may not know that a toothache medication may help.

The Mayo Clinic says it’s been a decade since a drug, a medicine called oral-coagulase-modified (OCM) and other medications, helped many people with severe pain, including those who had been treated with a drug called clindamycin.

But now a new study is providing some clues about how this drug works and how it might work for people with mild toothache.

The Mayo Clinic has used oral-COX-2 inhibitors, which are drugs that can stop the production of COX-1 in the blood, to treat severe toothaches.

But it’s not known how they work and whether they have any benefit for those with moderate or mild toothaches, which can be caused by infections or other conditions.

The researchers have used two drugs that they believe can treat moderate toothache, but the results of their study are not yet available.

Dr. Michael Siegel, who is the lead author of the study, says the researchers were surprised to find that OCM could help people with moderate toothaches without being as effective as the drugs that have been used.

“We were surprised that it works,” Siegel said.

Siegel and colleagues are now working to find out how OCM works and what its effects are on the human body.

They are also looking for studies to see if it works for people who are having chronic toothaches and for people in general.OCTA has been used for years to treat people with toothache who have no other treatment available, but Siegel says he and his colleagues have been testing it to see whether it can help people who have chronic toothache with mild pain or toothache that’s mild enough to be treated with medication.SIGEL: So we’ve found out that if we put this drug in a patient who has moderate pain, the drug works.

And if we get that patient off of the oral COX inhibitors, it will do the same thing.

SOURCE: NBC News: What is OCM?

What are the drugs doing?OCTASE is a generic name for a class of drugs called oral coagulases modified.

These drugs are approved to treat conditions like arthritis, arthritis-related urinary tract infections, chronic obstructive pulmonary disease, and some types of cancer.

The drugs can be given as injections or oral tablets, and they are designed to be delivered to the mouth or swallowed.

The drugs work by inhibiting COX2, a protein that produces COX1, the chemical messenger that transports pain signals to the brain.

OCTASE can block the enzyme that creates COXs.

Oscillating the level of COx2 in the body can reduce pain, but patients with severe tooth pain may need to take medications for days or weeks to achieve that level of relief.SINGEL: This is the first time we have seen that it could be effective and we haven’t seen a case where the drug has caused any side effects.

And we’re very interested in seeing how it affects the patient.

So, we’re looking at how the drug affects the human system and the body, how it works on the patient and how we can use this to help those patients.SALKER: This could be a very exciting area to work in, to find the mechanisms that might explain how COX inhibition affects the body.

We’re really interested in understanding how it’s working, what it does to the body and the human organism, Siegel added.

It’s a big area that we’re really going to be working in.